Outcomes: resolution of symptoms, quality of life and outcome of index consultation by setting
| Overall % (n) | ED % (n) | General practice % (n) | Pharmacy % (n) | p Value | |
|---|---|---|---|---|---|
| Resolution of symptoms at 2-week follow-up | (n=263) | (n=51) | (n=116) | (n=97) | 0.415* |
| Resolved | 39.2 (103) | 37.3 (19) | 35.7 (41) | 44.3 (43) | |
| Follow-up EQ-VAS | (n=261) | (n=50) | (n=115) | (n=96) | 0.054† |
| Mean (SD) | 77.4 (18.2) | 74.8 (19.6) | 75.5 (19.5) | 80.9 (15.3) | |
| Change in EQ-VAS | (n=259) | (n=50) | (n=113) | (n=96) | 0.726† |
| Mean (SD) | 8.43 (18.2) | 7.6 (17.9) | 7.8 (18.1) | 9.6 (18.5) | |
| Outcome of index consultation | (n=338) | (n=63) | (n=141) | (n=134) | |
| Sold or supplied medicines | (n=334) | (n=61) | (n=141) | (n=132) | <0.001* |
| Yes | 66.5 (222) | 31.1 (19) | 61.7 (87) | 87.9 (116) | |
| Sold or supplied items | (n=327) | (n=59) | (n=138) | (n=130) | <0.001* |
| Yes | 9.3 (35) | 37.3 (22) | 2.2 (3) | 7.7 (10) | |
| Satisfaction | (n=334) | (n=60) | (n=136) | (n=127) | 0.115*‡ |
| Satisfied | 64.7 (209) | 53.3 (32) | 66.2 (90) | 68.5 (87) | |
| Neither | 31.9 (103) | 45.0 (27) | 27.9 (38) | 29.9 (38) | |
| Dissatisfied | 3.4 (11) | 1.7 (1) | 5.9 (8) | 1.6 (2) | |
| Experience | (n=328) | (n=61) | (n=141) | (n=126) | 0.011§ |
| Median (IQR) | 10 (8–10) | 9 (7–10) | 10 (8–10) | 10 (8–10) | |
| Duration of wait (minutes) | (n=334) | (n=62) | (n=141) | (n=131) | <0.001§ |
| Median (IQR) | 5 (1–30) | 47.5 (30–86.25) | 15 (5–30) | 1 (0–2) | |
| Duration of consultation (minutes) | (n=332) | (n=61) | (n=141) | (n=130) | <0.001§ |
| Median (IQR) | 5 (2–10) | 10 (5–27.5) | 10 (5–10) | 2 (1–3) | |
| MISS 21 items¶ | (n=268) | (n=63) | (n=141) | (n=101) | |
| Total score: mean (SD) | 5.27 (0.97) | 5.39 (0.94) | 5.70 (1.01) | 4.75 (0.81) | <0.001† |
| Distress relief: mean (SD) | 4.97 (1.24) | 5.29 (1.14) | 5.39 (1.17) | 4.31 (1.09) | <0.001† |
| Communication: mean (SD) | 5.50 (1.19) | 5.43 (1.24) | 5.89 (1.16) | 5.05 (1.05) | <0.001† |
| Rapport: mean (SD) | 5.38 (1.06) | 5.48 (1.02) | 5.83 (1.32) | 4.83 (0.91) | <0.001† |
| Compliance intent: mean (SD) | 5.40 (1.10) | 5.41 (1.18) | 5.69 (1.05) | 5.04 (1.02) | <0.001† |
*Pearson χ2.
†ANOVA.
‡For 2×2 where neither and dissatisfied are combined.
§Kruskal-Wallis test.
¶n is for total score.
ANOVA, analysis of variance; ED, emergency department; MISS 21, Medicine Information Satisfaction Score; VAS, visual analogue scale.